122 related articles for article (PubMed ID: 38186655)
1. Corrigendum: Compound Dihuang Granule inhibits nigrostriatal pathway apoptosis in Parkinson's disease by suppressing the JNK/AP-1 pathway.
Wang L; Yang YF; Chen L; He ZQ; Bi DY; Zhang L; Xu YW; He JC
Front Pharmacol; 2023; 14():1320322. PubMed ID: 38186655
[TBL] [Abstract][Full Text] [Related]
2. Compound Dihuang Granule Inhibits Nigrostriatal Pathway Apoptosis in Parkinson's Disease by Suppressing the JNK/AP-1 Pathway.
Wang L; Yang YF; Chen L; He ZQ; Bi DY; Zhang L; Xu YW; He JC
Front Pharmacol; 2021; 12():621359. PubMed ID: 33897417
[TBL] [Abstract][Full Text] [Related]
3. Compound Dihuang Granule Changes Gut Microbiota of MPTP-Induced Parkinson's Disease Mice via Inhibiting TLR4/NF-κB Signaling.
He ZQ; Huan PF; Wang L; He JC
Neurochem Res; 2023 Dec; 48(12):3610-3624. PubMed ID: 37561259
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: Uncovering the pharmacology of Ginkgo biloba folium in the cell-type-specific targets of Parkinson's disease with a deep learning algorithm.
Yan YC; Xu ZH; Wang J; Yu WB
Front Pharmacol; 2022; 13():1115043. PubMed ID: 36712677
[TBL] [Abstract][Full Text] [Related]
5. Prediction of network pharmacology and molecular docking-based strategy to determine potential pharmacological mechanism of Liuwei Dihuang pill against tinnitus.
Wu Z; Zhu Z; Cao J; Wu W; Hu S; Deng C; Xie Q; Huang X; You C
Medicine (Baltimore); 2022 Nov; 101(46):e31711. PubMed ID: 36401375
[TBL] [Abstract][Full Text] [Related]
6. Study on the Mechanism of Liuwei Dihuang Pills in Treating Parkinson's Disease Based on Network Pharmacology.
Lin D; Zeng Y; Tang D; Cai Y
Biomed Res Int; 2021; 2021():4490081. PubMed ID: 34746302
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: The Efficacy and Safety of Qiming Granule for Dry Eye Disease: A Systematic Review and Meta-Analysis.
Yang M; Hu Z; Yue R; Yang L; Zhang B; Chen Y
Front Pharmacol; 2020; 11():597639. PubMed ID: 33362551
[TBL] [Abstract][Full Text] [Related]
8. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death.
Tseng YT; Chang FR; Lo YC
Phytomedicine; 2014 Apr; 21(5):724-33. PubMed ID: 24411708
[TBL] [Abstract][Full Text] [Related]
9. Anti-cervical cancer effects of Compound Yangshe granule through the PI3K/AKT pathway based on network pharmacology.
Ma C; Gu Y; Liu C; Tang X; Yu J; Li D; Liu J
J Ethnopharmacol; 2023 Jan; 301():115820. PubMed ID: 36220511
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: Bushen huoxue decoction inhibits RANKL-stimulated osteoclastogenesis and glucocorticoid-induced bone loss by modulating the NF-κB, ERK, and JNK signaling pathways.
Liu Y; Fu B; Li X; Chen C; Li X; Xu L; Wang B
Front Pharmacol; 2023; 14():1148908. PubMed ID: 36925639
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum: Wuzi Yanzong pill-Based on network pharmacology and
Chen WQ; Ding CF; Yu J; Wang CY; Wan LY; Hu HM; Ma JX
Front Pharmacol; 2022; 13():1129448. PubMed ID: 36712666
[TBL] [Abstract][Full Text] [Related]
12. Effect of Zishenpingchan granule prepared from Chinese medicinal substances on the c-Jun N-terminal protein kinase pathway in mice with Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Ye Q; Yuan X; Zhou J; Yuan C; Yang X
J Tradit Chin Med; 2017 Apr; 37(2):244-51. PubMed ID: 29960635
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum: Revealing the mechanism of Huazhi Rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology.
Liu Y; Tan Y; Huang J; Wu C; Fan X; Stalin A; Lu S; Wang H; Zhang J; Zhang F; Wu Z; Li B; Huang Z; Chen M; Cheng G; Mou Y; Wu J
Front Pharmacol; 2023; 14():1243304. PubMed ID: 37564177
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: A Chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial.
Wan Y; Yang J; Ma T; Wang W; Wang H; Sun W; Ye W; Yang L; Kou Q
Front Pharmacol; 2022; 13():1074679. PubMed ID: 36408226
[TBL] [Abstract][Full Text] [Related]
15. [Intervention mechanism of psychological sub-health by Baihe Dihuang Tang based on network pharmacology].
Zhao L; Wu YF; Gao Y; Xiang H; Qin XM; Tian JS
Yao Xue Xue Bao; 2017 Jan; 52(1):99-105. PubMed ID: 29911798
[TBL] [Abstract][Full Text] [Related]
16. Study on the mechanism of Qiju Dihuang pill in the treatment of ophthalmic diseases based on systems pharmacology.
Liu F; Tian M
Medicine (Baltimore); 2022 Aug; 101(31):e30033. PubMed ID: 35945711
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: An integrative serum pharmacology-based approach to study the anti-tumor activity of B. Paniculatum aqueous bulb extract on the human hepatocellular carcinoma cell line BEL-7404.
Feng X; Ma G; Shi H; Wang Y; Chao X
Front Pharmacol; 2022; 13():1054143. PubMed ID: 36425573
[TBL] [Abstract][Full Text] [Related]
18. Uncovering the mechanism of Qidan Dihuang Granule in the treatment of diabetic kidney disease combined network pharmacology, UHPLC-MS/MS with experimental validation.
Xiang L; Cai X; Zhao X; Liu Y; Xiao Y; Jiang P; Yin L; Song D; Jiang X
Heliyon; 2023 Nov; 9(11):e21714. PubMed ID: 37954274
[TBL] [Abstract][Full Text] [Related]
19. Erratum: A Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of LiuWei DiHuang Pill in Treating Type 2 Diabetes Mellitus [Corrigendum].
He D; Huang JH; Zhang ZY; Du Q; Peng WJ; Yu R; Zhang SF; Zhang SH; Qin YH
Drug Des Devel Ther; 2020; 14():949. PubMed ID: 32184563
[TBL] [Abstract][Full Text] [Related]
20. Network Pharmacology Analysis on Zhichan Powder in the Treatment of Parkinson's Disease.
Li J; Qi X; Sun Y; Zhang Y; Chen J
Comb Chem High Throughput Screen; 2020; 23(1):28-40. PubMed ID: 31899674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
